Corvus Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -21 | -23 | ||
EBITDA | -8,085 | -7,234 | -5,912 | -6,230 |
EBIT | -8,105 | -7,255 | -5,933 | -6,253 |
Net Income | -12,113 | -40,217 | -4,262 | -5,701 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -8,465 | -6,321 | -5,481 | -5,157 |
Cash | 8,740 | 4,680 | 14,841 | 7,456 |
Basic Shares | 60,985 | 66,701 | 59,710 | 49,038 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -151 | -367 | -460 | |
EBITDA | -27,548 | -26,878 | -40,940 | -42,781 |
EBIT | -60,469 | -27,029 | -41,307 | -43,241 |
Net Income | -62,293 | -27,029 | -50,049 | -38,200 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -25,424 | -23,969 | -27,292 | -36,720 |
Cash | 8,740 | 12,620 | 13,159 | 63,458 |
Basic Shares | 60,985 | 48,025 | 46,553 | 41,854 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.14 |
2024-09-30 | -$0.60 |
2024-06-30 | -$0.04 |
2024-03-31 | -$0.12 |
